Inactive Instrument
Acusphere, Inc. Stock Other OTC
Stocks
US00511R8705
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 13-11-06 | Acusphere Appoints William Ramage as Chief Development Officer | CI |
| 13-10-21 | Acusphere, Inc. has Changed its Ticker to ACUS from ACUSD | CI |
| Market Cap | 3.46M 3.03M 2.78M 2.59M 4.92M 330M 5M 33.42M 12.99M 162M 13.01M 12.73M 559M | P/E 2006 |
-1.06x | P/E 2007 | -0.49x |
|---|---|---|---|---|---|
| Enterprise Value | -11.29M -9.87M -9.07M -8.46M -16.04M -1.08B -16.28M -109M -42.34M -529M -42.39M -41.48M -1.82B | EV / Sales 2006 |
9,811,030x | EV / Sales 2007 | 5,744,305x |
| Free-Float |
100% | Yield 2006 * |
-
| Yield 2007 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.08% | +1.68% | +13.48% | +82.86% | 48B | |
| +3.36% | +7.06% | +73.53% | +119.26% | 36.89B | |
| +0.36% | +0.59% | -3.16% | +43.23% | 12.37B | |
| +0.82% | +2.56% | +15.14% | +95.54% | 11.95B | |
| +0.58% | +0.58% | +32.90% | +119.07% | 9.01B | |
| -0.82% | +0.17% | +20.42% | +45.23% | 7.2B | |
| +1.22% | +1.60% | +55.46% | -4.13% | 7.05B | |
| +9.99% | +32.94% | -15.50% | +21.82% | 6.58B | |
| +2.24% | +3.36% | +21.50% | +238.20% | 6.55B | |
| Average | +1.97% | +4.24% | +23.75% | +84.56% | 16.18B | |
| Weighted average by Cap. | +1.58% | +3.35% | +30.04% | +90.16% |
| 2006 | 2007 | |
|---|---|---|
| Net sales | 1.78 1.56 1.43 1.33 2.53 169.58 2.57 17.18 6.68 83.36 6.69 6.54 287.24 | 2.67 2.33 2.14 2 3.79 253.94 3.85 25.72 10 124.82 10.01 9.8 430.13 |
| Net income | -61.09M -53.4M -49.08M -45.75M -86.77M -5.82B -88.08M -589M -229M -2.86B -229M -224M -9.85B | -53.73M -46.97M -43.17M -40.24M -76.32M -5.12B -77.47M -518M -201M -2.51B -202M -197M -8.67B |
| Net Debt | -52.87M -46.22M -42.48M -39.59M -75.1M -5.03B -76.24M -510M -198M -2.47B -198M -194M -8.53B | -14.76M -12.9M -11.86M -11.05M -20.96M -1.41B -21.28M -142M -55.33M -691M -55.4M -54.21M -2.38B |
Employees
-
Sector
Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
